Board of Directors

Karel Boone

Chairman and Member of the Audit Committee

Commercial Engineer (KUL), Karel Boone started in 1966 as an executive member of the Board of Directors of Lotus Bakeries (Lotus Biscuits at this time) and became CEO in 1974 when Lotus Biscuits merged with Corona. He became also Chairman of the Board of Directors in 1992. He is a member of the following Boards of Directors : Axa Belgium, Banque Degroof, Bois Sauvage, Vandemoortele (Chairman) and Van Steenberge. He is active in professional organizations : he has been Chairman of the Federation of Belgian Companies, Chairman of Choprabisco (Biscuits, Chocolate and Confectionery) and member of the Board of Fevia (Food in Belgium).

Countess Diego du Monceau de Bergendal

Married and mother of three children, Countess du Monceau de Bergendal graduated in 1972 in Applied Economics from UCL. She followed courses in International Relations at the Kennedy School of Harvard University and in Soil Science, Animal Science and Zoology at the Agricultural and Technical College of Farmingdale (N.Y.). Since 1982 she is a member of the Board of Directors of Financière de Tubize. She is on the Board of Solvac S.A.

Dr Roch Doliveux

Chief Executive Officer and Chairman of the Executive Committee

Appointed in January 2005. Previously Director-General of UCB's Pharma Sector; CEO of Pierre Fabre Pharmaceuticals; President of Schering-Plough International, plus other posts with this company in the U.S.A., France and Belgium. Started at Ciba-Geigy (now Novartis), working in Switzerland, Peru and France. He is a member of the Board of Directors of UCB, and also a member of the Board of the European Federation of Pharmaceutical Industries & Associations (EFPIA).

H.R.H. Prince Lorenz of Belgium

Independent Director, Member of the Audit Committee

Prince Lorenz has studied in Switzerland and Austria Economics. After one and a half years spent in various banks in London, Paris and Rome, in 1983 he started a career at E. Gutzwiller & Cie, Banquiers in Bâle and became Managing Partner.

In 1993, he spent one year as Consultant for Swift S.C. CEO and from 1995 he became Advisor to the Board of Directors of BNP Paribas in Paris. Until 2003 he was a member of various Boards of Directors in Europe.

Armand De Decker

Independent Director

Armand De Decker holds a Master of Law Degree from the University of Brussels (ULB - Belgium) and started as a lawyer.  In parallel, as from 1979, he pursued a political career within the Liberal Party ("Parti Réformateur Liberal").   In 1981, he was elected to the Belgian Chamber of Representatives where he served until 1995.  In 1995, he was elected to the Belgian Senate, and re-elected in 1999, 2003 and 2007. He served as President of the Council of the Brussels-Capital Region from 1995 to 1999. And from 1999 to 2004 he was President of the Senate.  From July 20, 2004, he served as the Minister responsible for International Development Cooperation in the Belgian Federal Government.  Armand De Decker currently is Mayor of Uccle (a commune of Brussels) and has been re-elected President of the Senate since July 12, 2007.  Mr. De Decker has received numerous special recognitions from many countries for different contributions (a.o.Belgian, France, Spain, Sweden, Finland, Denmark, Italy, Mexico,...) and has various mandates in organizations such as "Alzheimer Belgian Association", Belgian Royal Institute of International Relations, Belgian Center of
Reference for the Central Africa Expertise.

Dr Peter Fellner

Director

Peter Fellner (1943), who is British, is Executive Chairman of Vernalis plc, and also chairman of the privately held UK biotechnology company, Astex Therapeutics Ltd and a Non-Executive Director of Qinetiq Group plc, one of Europe's largest technology-based companies. He is also a Director of Evotec AG, Bespak plc, Acambis plc and Isis Innovation Ltd. In addition he is a member of the UK Medical Research Council and a member of the Apax Healthcare Advisory Board. He was previously chairman of Celltech Group plc, having served as its CEO from 1990 to 2003. He oversaw its development into the U.K.'s largest biotechnology company, until its acquisition by UCB in 2004. Before joining Celltech, Peter Fellner served as CEO of Roche U.K., from 1986 to 1990. From 1984 to 1986 he was Director of the Roche U.K. Research Centre.

Norman J-Ornstein

Independent Director

Norman J-Ornstein is a resident scholar at the American Enterprise Institute for Public Policy Research based in Washington D.C., USA, and counsels government campaign commissions.  He also serves as an election analyst for CBS News and writes in several US newspapers in parallel to having published several books related to US politics.  Mr Ornstein has a B.A. from the University of Minnesota, from which he also received an honorary Doctor of Laws degree, and a M.A. and PhD from the University of Michigan.  He served as a member the Board of the Public Broadcasting Service (PBS) and is currently on the Board of Directors of the Campaign Legal Center, as well as of the Board of Trustees of the US Capitol Historical Society.

Jean-Pierre Kinet

Independent Director

Jean-Pierre Kinet holds a medical degree (MD) from the University of Liège. He is currently a full Professor of Pathology at Harvard Medical School and at one of the Harvard affiliated hospitals, the Beth Israel Deaconess Medical Center in Boston. He is a member of numerous Harvard, US and International committees such as various National Institutes of Health (NIH) expert panels and the International Strategic Committee of Biowin (Health Cluster of Wallonia). He has a large experience in the research and development of novel therapies and is a board member of several biotechnology companies.

Thomas Leysen

Independent Director (from 01/01/2009)



Master in Law (University of Leuven-Belgium), Thomas Leysen started his career in the maritime business in Hamburg, London and Tokyo, then within the Transcor group.  In 1989, he joined Société Générale de Belgique and restructured their international trading activities.  He joined Umicore in 1993 as member of the Executive Committee, and successively managed several industrial divisions.  He became Executive Vice President of the company in 1998.  He has been the Chief Executive Officer of Umicore since May 2000.   Thomas Leysen is also Chairman of the Board of Corelio, director of CMB and IMEC and member of the Supervisory Board of Bank Metzler in Frankfurt.

Gerhard N. Mayr

Independent Director, Member of the Remuneration and Nominations Committee

Gerhard N. Mayr, Independent Director, Member of the Remuneration and Appointments Committee. A native of Austria, Gerhard Mayr received a master's degree in chemical engineering from the Swiss Federal Institute of Technology (Zurich, Switzerland) in 1969, and a master of business administration degree from Stanford University in 1972.

In March, 2004, Gerhard Mayr retired as executive vice president of pharmaceutical operations at Eli Lilly & Company after 32 years of service. He had been responsible for global pharmaceutical operations and sales and marketing worldwide at Lilly - a leading innovation-driven corporation.

Gerhard Mayr is past chairman of both the International Executive Committee and the Europe Committee of the Pharmaceutical Research Manufacturers of America. He was a board member of the European Federation of the Pharmaceutical Industry from 1995-97 and 2000-2002.

Member of the Board of Bank Austria-Creditanstalt AG, and a member of the board of OMV AG. He is a member of the Apax Healthcare Advisory Board, a member of the board of Project Hope, and a board member of the Vienna Science-Research and Technology Foundation.

Count Arnoud de Pret Roose de Calesberg

Director, Chairman of the Audit Committee

Count Arnoud de Pret (1944), Director, Chairman of the Audit Committee, consultant. Commercial Engineer from UCL (Louvain). He started his career as Credit Officer with Morgan Guaranty Trust of New-York (Brussels and Antwerp) in 1971. He became Treasurer and Corporate Finance Manager Cockerill (Liège) in 1978. He joined UCB (Brussels) in 1981 as Chief Financial Officer and Member of the Executive Committee. He became in 1990, Treasurer and Corporate Finance Manager at Société Générale de Belgique before joining Umicore in 1991 as Chief Financial Officer and Member of the Management Committee until May 2000.

He is Director and Member of the Audit Committee of InBev, Umicore, Sibelco, Delhaize Group and serves on the Advisory Board of Euronext.

Mrs Jean van Rijckevorsel

Director

She is married and mother of two children. Mrs Jean van Rijckevorsel is a member of the Board of Directors of privately owned investment companies.

Gaëtan van de Werve

Director, Member of the Remuneration and Nominations Committee

Doctor of Law (KUL), he also holds an MBA from Vlerick Management School (RUG) in 1972.

He joined Petrofina SA in 1973 where he held various management responsibilities in the areas of supply, sales and marketing. He was the managing director of Sigma Paints (Thailand) from 1983 to 1985.

In 1992, he joined the European Petroleum Industry Association (EUROPIA) as executive officer, responsible for Environment, tax and legal.

In 1996, he joined the Belgian Oil Industry Association as Secretary-general.

Gaëtan van de Werve is not member of the Board of another listed company.

Patrick Schwarz-Schütte

Director

Patrick Schwarz-Schütte is Managing Director of Black Horse Investments GmbH in Dusseldorf, Germany. He was born in 1956 and following school, he finished his military service in the German Armed Forces as a reserve officer. After completing a commercial training in the pharmaceutical industry in 1979 and finishing his studies of business administration at University of Hamburg in 1982, he joined Booz, Allen & Hamilton, as a management consultant. He started his career at SCHWARZ PHARMA in 1984, first as assistant to the Executive Board, and from 1988 onwards as Member of the Executive Board. He took over the position of the Chairman in 1992 and left the company at the end of 2006, after SCHWARZ PHARMA had been acquired by UCB S.A, Belgium.

He is Chairman of the Board of the German-French Chamber of Industry and Commerce in Paris, Member of the Board of German-American Chamber of Commerce Inc., New York and Member of the Supervisory Board of both, Victoria Versicherung AG and Victoria Lebensversicherung AG in Dusseldorf, Germany.

Patrick Schwarz-Schütte is married and has four children.